JP2019529443A5 - - Google Patents

Download PDF

Info

Publication number
JP2019529443A5
JP2019529443A5 JP2019515462A JP2019515462A JP2019529443A5 JP 2019529443 A5 JP2019529443 A5 JP 2019529443A5 JP 2019515462 A JP2019515462 A JP 2019515462A JP 2019515462 A JP2019515462 A JP 2019515462A JP 2019529443 A5 JP2019529443 A5 JP 2019529443A5
Authority
JP
Japan
Prior art keywords
sulfonyl
hydroxy
pyrrolidine
hydroxymethyl
oxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019515462A
Other languages
English (en)
Japanese (ja)
Other versions
JP7025414B2 (ja
JP2019529443A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/055700 external-priority patent/WO2018055524A1/en
Publication of JP2019529443A publication Critical patent/JP2019529443A/ja
Publication of JP2019529443A5 publication Critical patent/JP2019529443A5/ja
Application granted granted Critical
Publication of JP7025414B2 publication Critical patent/JP7025414B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019515462A 2016-09-20 2017-09-20 Trpv4拮抗薬 Active JP7025414B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662396991P 2016-09-20 2016-09-20
US62/396,991 2016-09-20
US201762482296P 2017-04-06 2017-04-06
US62/482,296 2017-04-06
PCT/IB2017/055700 WO2018055524A1 (en) 2016-09-20 2017-09-20 Trpv4 antagonists

Publications (3)

Publication Number Publication Date
JP2019529443A JP2019529443A (ja) 2019-10-17
JP2019529443A5 true JP2019529443A5 (enExample) 2021-02-12
JP7025414B2 JP7025414B2 (ja) 2022-02-24

Family

ID=60084020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019515462A Active JP7025414B2 (ja) 2016-09-20 2017-09-20 Trpv4拮抗薬

Country Status (22)

Country Link
US (2) US10588891B2 (enExample)
EP (1) EP3515887B1 (enExample)
JP (1) JP7025414B2 (enExample)
KR (1) KR20190047724A (enExample)
CN (1) CN109952289B (enExample)
AU (1) AU2017330618A1 (enExample)
CA (1) CA3036929A1 (enExample)
CY (1) CY1124682T1 (enExample)
DK (1) DK3515887T3 (enExample)
ES (1) ES2890986T3 (enExample)
HR (1) HRP20211457T1 (enExample)
HU (1) HUE056059T2 (enExample)
LT (1) LT3515887T (enExample)
PL (1) PL3515887T3 (enExample)
PT (1) PT3515887T (enExample)
RS (1) RS62317B1 (enExample)
RU (1) RU2019111882A (enExample)
SI (1) SI3515887T1 (enExample)
SM (1) SMT202100561T1 (enExample)
TW (1) TW201825458A (enExample)
UY (1) UY37410A (enExample)
WO (1) WO2018055524A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109790116B (zh) 2016-09-20 2022-10-28 葛兰素史密斯克莱知识产权(第2 号)有限公司 Trpv4拮抗剂
EP3515889A1 (en) 2016-09-20 2019-07-31 GlaxoSmithKline Intellectual Property (No. 2) Limited Trpv4 antagonists
TW201825458A (zh) * 2016-09-20 2018-07-16 英商葛蘭素史克智慧財產(第二)有限公司 Trpv4拮抗劑
CN108836972A (zh) * 2018-08-16 2018-11-20 青岛大学 Ws6对trp通道的作用
TWI878266B (zh) 2019-02-15 2025-04-01 愛爾蘭商博士倫愛爾蘭有限公司 治療眼表痛之方法
JP6994061B2 (ja) 2019-02-15 2022-01-14 ノバルティス アーゲー 4-(7-ヒドロキシ-2-イソプロピル-4-オキソ-4h-キナゾリン-3-イル)-ベンゾニトリルの製剤
JP7624745B2 (ja) * 2019-11-21 2025-01-31 ユニバーシティ オブ ユタ リサーチ ファウンデーション Trpv4受容体リガンド
TWI899220B (zh) 2020-04-30 2025-10-01 日商拉夸里亞創藥股份有限公司 作為trpv4拮抗劑之嘧啶-4(3h)-酮衍生物
WO2021233752A1 (en) 2020-05-19 2021-11-25 Bayer Aktiengesellschaft Trpa1 antagonists for the treatment of diseases associated with pain and inflammation
WO2022013225A1 (en) 2020-07-13 2022-01-20 Precirix N.V. Antibody fragment against folr1
EP4183415A4 (en) 2020-07-16 2024-07-17 RaQualia Pharma Inc. Trpv4 inhibitor as therapeutic drug for eye disease
CN112574090B (zh) * 2020-11-23 2022-04-29 浙大城市学院 一种含硫的多取代吡咯类化合物及其制备方法
WO2023203135A1 (en) 2022-04-22 2023-10-26 Precirix N.V. Improved radiolabelled antibody
WO2023213801A1 (en) 2022-05-02 2023-11-09 Precirix N.V. Pre-targeting

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1308A (en) 1979-12-06 1985-12-06 Glaxo Group Ltd Device for dispensing medicaments
ATE23272T1 (de) 1981-07-08 1986-11-15 Draco Ab Pulverinhalator.
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
GR79615B (enExample) 1982-10-08 1984-10-31 Glaxo Group Ltd
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
DK163640C (da) 1985-07-30 1992-08-17 Glaxo Group Ltd Apparat til administrering af medikamenter
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
SK280967B6 (sk) 1990-03-02 2000-10-09 Glaxo Group Limited Inhalačný prístroj
WO1998008815A1 (en) 1996-08-28 1998-03-05 The Procter & Gamble Company Substituted cyclic amine metalloprotease inhibitors
GB9700226D0 (en) 1997-01-08 1997-02-26 Glaxo Group Ltd Inhalation device
DK1461315T3 (da) 2001-12-06 2009-11-16 Cornell Res Foundation Inc Katalytisk carbonylering af tre- og fireleddede heterocykler
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
EP1605752B1 (en) 2003-03-27 2011-09-14 Cytokinetics, Inc. Sulfonamides for the treatment of congestive heart failure, their compositions and uses.
GB0317374D0 (en) 2003-07-24 2003-08-27 Glaxo Group Ltd Medicament dispenser
SG150524A1 (en) 2004-02-16 2009-03-30 Glaxo Group Ltd Counter for use with a medicament dispenser
AR048523A1 (es) 2004-04-07 2006-05-03 Kalypsys Inc Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos
JP2007534755A (ja) 2004-04-28 2007-11-29 メルク エンド カムパニー インコーポレーテッド ケモカイン受容体活性のモジュレーターとなる3,3−ジ置換テトラヒドロピラニルシクロペンチルアミド
JP2007538106A (ja) 2004-05-20 2007-12-27 イーラン ファーマスーティカルズ、インコーポレイテッド γセクレターゼのN−環式スルホンアミド阻害剤
CN1329374C (zh) 2004-06-09 2007-08-01 上海靶点药物有限公司 作为ccr5拮抗剂的化合物
BRPI0513262A (pt) 2004-07-12 2008-04-29 Bayer Cropscience Ag heterociclos substituìdos
GB0418278D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Medicament dispenser
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
AR058289A1 (es) 2005-12-12 2008-01-30 Glaxo Group Ltd Colector para ser usado en dispensador de medicamento
AR058558A1 (es) 2005-12-21 2008-02-13 Schering Corp Derivados de anilina sustituida utiles como antagonistas de la histamina h3
EP1981596A4 (en) 2006-01-11 2010-09-01 Glaxosmithkline Llc NEW CONNECTIONS
CN101595107A (zh) 2006-06-30 2009-12-02 先灵公司 能提高p53活性的有取代哌啶及其用途
WO2008091863A1 (en) 2007-01-23 2008-07-31 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
EP2244571A4 (en) 2008-01-17 2014-02-19 Purdue Research Foundation SMALL MOLECULAR INHIBITORS OF HIV PROTEASES
DE102008008838A1 (de) * 2008-02-13 2009-08-20 Bayer Healthcare Ag Cycloalkoxy-substituierte 4-Phenyl-3,5-dicyanopyridine und ihre Verwendung
KR20110026481A (ko) 2008-06-20 2011-03-15 메타볼렉스, 인코포레이티드 아릴 gpr119 작동약 및 이의 용도
EA201590951A1 (ru) 2012-11-16 2015-08-31 Бристол-Майерс Сквибб Компани Дигидропиразольные модуляторы gpr40
CN103896946B (zh) 2012-12-28 2018-04-03 浙江导明医药科技有限公司 用于预防及治疗多种自身免疫疾病的新化合物
TW201524952A (zh) 2013-03-15 2015-07-01 Araxes Pharma Llc Kras g12c之共價抑制劑
EP2970215B1 (en) 2013-03-15 2019-04-17 AbbVie Deutschland GmbH & Co. KG Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
JP6272832B2 (ja) 2013-04-04 2018-01-31 武田薬品工業株式会社 複素環化合物
RU2710928C2 (ru) 2014-07-31 2020-01-14 Инсерм (Институт Насьональ Де Ла Сант Эт Де Ла Решерш Медикаль) Антагонисты рецептора flt3
CN109790116B (zh) 2016-09-20 2022-10-28 葛兰素史密斯克莱知识产权(第2 号)有限公司 Trpv4拮抗剂
EP3515889A1 (en) 2016-09-20 2019-07-31 GlaxoSmithKline Intellectual Property (No. 2) Limited Trpv4 antagonists
TW201825458A (zh) * 2016-09-20 2018-07-16 英商葛蘭素史克智慧財產(第二)有限公司 Trpv4拮抗劑

Similar Documents

Publication Publication Date Title
JP2019529443A5 (enExample)
RU2019111882A (ru) Антагонисты trpv4
JP2019532052A5 (enExample)
US20240139194A1 (en) Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
JP2019532054A5 (enExample)
US12458642B2 (en) Metalloenzyme inhibitor compounds
US7999006B2 (en) Methods of using MEK inhibitors
RU2015139590A (ru) ИНГИБИРУЮЩЕЕ Trk СОЕДИНЕНИЕ
HRP20171913T1 (hr) Aminopirimidinilni spojevi kao inhibitori jak
JP2016526576A5 (enExample)
HRP20212000T1 (hr) Aminotriazolopiridini kao inhibitori kinaze
JP2015517566A5 (enExample)
JP2017535561A5 (enExample)
HRP20161011T1 (hr) Aril dihidropiridinoni i piperidinoni kao inhibitori mgat2
CA2703125A1 (en) Pyrazinyl-substituted pyrrolo[2,3-b]pyridines, compositions thereof, and their use in the treatment of cancer
JP2017511794A5 (enExample)
JP2014500322A5 (enExample)
RU2009133846A (ru) Новые производные гидантоина в качестве ингибиторов металлопротеиназ
RU2019110821A (ru) Антагонисты trpv4
RU2007126746A (ru) Новые производные гидантоина в качестве ингибиторов металлопротеиназ
US11136309B2 (en) Metalloenzyme inhibitor compounds
WO2024178390A1 (en) Covalent modifiers of akt1 and uses thereof
JP2008524211A5 (enExample)
CN114206342A (zh) 变构egfr抑制剂及其使用方法
JP5583841B2 (ja) 新規なフェニルピリジン誘導体及びこれを含有する医薬